Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Acta Cirúrgica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000100204 |
Resumo: | Abstract Purpose Patients with diabetes are vulnerable to myocardial I/R (ischaemia/reperfusion) injury, but are not responsive to IPO (ischaemic post-conditioning). We hypothesized that decreased cardiac Adiponectin (APN) is responsible for the loss of diabetic heart sensitivity to IPO cardioprotecton. Methods Diabetic rats were subjected to I/R injury (30 min of LAD occlusion followed by 120 min of reperfusion). Myocardial infarct area was determined by TTC staining. Cardiac function was monitored by a microcatheter. ANP, 15-F2t-isoprostane, nitrotyrosine and MDA were measured by assay kits. Levels of p-Akt, total-Akt and GAPDH were determined by Western Blot. Results Diabetic rats subjected to myocardial IR exhibited severe myocardial infarction and oxidative stress injury, lower APN in the plasma and cardiac p-Akt expression ( P <0.05). IPO significantly attenuated myocardial injury and up-regulated plasma APN content and cardiac p-Akt expression in non-diabetic rats but not in diabetic rats. Linear correlation analysis showed that the expression of adiponectin was positively correlated with p-Akt and negatively correlated with myocardial infarction area ( P <0.01). Conclusion Protective effect of IPO was tightly correlated with the expression of adiponectin, exacerbation of I/R injury and ineffectiveness of IPO was partially due to the decline of adiponectin and inactivation of Akt in diabetes mellitus. |
id |
SBDPC-1_a8585c764e20a86b6feb19ccf3a0b5d4 |
---|---|
oai_identifier_str |
oai:scielo:S0102-86502020000100204 |
network_acronym_str |
SBDPC-1 |
network_name_str |
Acta Cirúrgica Brasileira (Online) |
repository_id_str |
|
spelling |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioningAdiponectinDiabetesReperfusion InjuryIschemic PostconditioningAbstract Purpose Patients with diabetes are vulnerable to myocardial I/R (ischaemia/reperfusion) injury, but are not responsive to IPO (ischaemic post-conditioning). We hypothesized that decreased cardiac Adiponectin (APN) is responsible for the loss of diabetic heart sensitivity to IPO cardioprotecton. Methods Diabetic rats were subjected to I/R injury (30 min of LAD occlusion followed by 120 min of reperfusion). Myocardial infarct area was determined by TTC staining. Cardiac function was monitored by a microcatheter. ANP, 15-F2t-isoprostane, nitrotyrosine and MDA were measured by assay kits. Levels of p-Akt, total-Akt and GAPDH were determined by Western Blot. Results Diabetic rats subjected to myocardial IR exhibited severe myocardial infarction and oxidative stress injury, lower APN in the plasma and cardiac p-Akt expression ( P <0.05). IPO significantly attenuated myocardial injury and up-regulated plasma APN content and cardiac p-Akt expression in non-diabetic rats but not in diabetic rats. Linear correlation analysis showed that the expression of adiponectin was positively correlated with p-Akt and negatively correlated with myocardial infarction area ( P <0.01). Conclusion Protective effect of IPO was tightly correlated with the expression of adiponectin, exacerbation of I/R injury and ineffectiveness of IPO was partially due to the decline of adiponectin and inactivation of Akt in diabetes mellitus.Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000100204Acta Cirúrgica Brasileira v.35 n.1 2020reponame:Acta Cirúrgica Brasileira (Online)instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)instacron:SBDPC10.1590/s0102-865020200010000007info:eu-repo/semantics/openAccessCao,ChenLiu,Hui-minLi,WeiWu,YangLeng,YanXue,RuiChen,RongTang,Ling-huaSun,QianXia,ZhongyuanTang,Qi-zhuShen,Di-feiMeng,Qing-taoeng2020-03-18T00:00:00Zoai:scielo:S0102-86502020000100204Revistahttps://www.bvs-vet.org.br/vetindex/periodicos/acta-cirurgica-brasileira/https://old.scielo.br/oai/scielo-oai.php||sgolden@terra.com.br0102-86501678-2674opendoar:2020-03-18T00:00Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)false |
dc.title.none.fl_str_mv |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning |
title |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning |
spellingShingle |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning Cao,Chen Adiponectin Diabetes Reperfusion Injury Ischemic Postconditioning |
title_short |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning |
title_full |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning |
title_fullStr |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning |
title_full_unstemmed |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning |
title_sort |
Role of adiponectin in diabetes myocardial ischemia-reperfusion injury and ischemic postconditioning |
author |
Cao,Chen |
author_facet |
Cao,Chen Liu,Hui-min Li,Wei Wu,Yang Leng,Yan Xue,Rui Chen,Rong Tang,Ling-hua Sun,Qian Xia,Zhongyuan Tang,Qi-zhu Shen,Di-fei Meng,Qing-tao |
author_role |
author |
author2 |
Liu,Hui-min Li,Wei Wu,Yang Leng,Yan Xue,Rui Chen,Rong Tang,Ling-hua Sun,Qian Xia,Zhongyuan Tang,Qi-zhu Shen,Di-fei Meng,Qing-tao |
author2_role |
author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Cao,Chen Liu,Hui-min Li,Wei Wu,Yang Leng,Yan Xue,Rui Chen,Rong Tang,Ling-hua Sun,Qian Xia,Zhongyuan Tang,Qi-zhu Shen,Di-fei Meng,Qing-tao |
dc.subject.por.fl_str_mv |
Adiponectin Diabetes Reperfusion Injury Ischemic Postconditioning |
topic |
Adiponectin Diabetes Reperfusion Injury Ischemic Postconditioning |
description |
Abstract Purpose Patients with diabetes are vulnerable to myocardial I/R (ischaemia/reperfusion) injury, but are not responsive to IPO (ischaemic post-conditioning). We hypothesized that decreased cardiac Adiponectin (APN) is responsible for the loss of diabetic heart sensitivity to IPO cardioprotecton. Methods Diabetic rats were subjected to I/R injury (30 min of LAD occlusion followed by 120 min of reperfusion). Myocardial infarct area was determined by TTC staining. Cardiac function was monitored by a microcatheter. ANP, 15-F2t-isoprostane, nitrotyrosine and MDA were measured by assay kits. Levels of p-Akt, total-Akt and GAPDH were determined by Western Blot. Results Diabetic rats subjected to myocardial IR exhibited severe myocardial infarction and oxidative stress injury, lower APN in the plasma and cardiac p-Akt expression ( P <0.05). IPO significantly attenuated myocardial injury and up-regulated plasma APN content and cardiac p-Akt expression in non-diabetic rats but not in diabetic rats. Linear correlation analysis showed that the expression of adiponectin was positively correlated with p-Akt and negatively correlated with myocardial infarction area ( P <0.01). Conclusion Protective effect of IPO was tightly correlated with the expression of adiponectin, exacerbation of I/R injury and ineffectiveness of IPO was partially due to the decline of adiponectin and inactivation of Akt in diabetes mellitus. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000100204 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502020000100204 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/s0102-865020200010000007 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia |
publisher.none.fl_str_mv |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia |
dc.source.none.fl_str_mv |
Acta Cirúrgica Brasileira v.35 n.1 2020 reponame:Acta Cirúrgica Brasileira (Online) instname:Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC) instacron:SBDPC |
instname_str |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC) |
instacron_str |
SBDPC |
institution |
SBDPC |
reponame_str |
Acta Cirúrgica Brasileira (Online) |
collection |
Acta Cirúrgica Brasileira (Online) |
repository.name.fl_str_mv |
Acta Cirúrgica Brasileira (Online) - Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC) |
repository.mail.fl_str_mv |
||sgolden@terra.com.br |
_version_ |
1752126445491060736 |